Belsomra is a brand name for the drug suvorexant, which is used to treat insomnia [1]. It is manufactured by Merck & Co. [1]. Belsomra is a first-in-class orexin receptor antagonist that works by blocking the wake-promoting action of orexin in the brain [2].
How does Belsomra work?
Belsomra targets the orexin system, a network of nerve cells in the brain that promote wakefulness [3]. By blocking the binding of orexin to its receptors, Belsomra reduces the stimulation of wakefulness pathways, thereby helping individuals fall asleep and stay asleep [2]. This mechanism is distinct from other sleep medications that work by broadly depressing the central nervous system [2].
When does Belsomra's patent expire?
The patent landscape for Belsomra involves multiple patents covering the composition of matter, methods of use, and manufacturing processes [4]. Information on specific patent expiry dates can be found on specialized resources like DrugPatentWatch.com, which tracks pharmaceutical patent data [4].
What are the alternatives to Belsomra?
Other insomnia treatments include other classes of hypnotics like benzodiazepines, non-benzodiazepine hypnotics (e.g., zolpidem, eszopiclone), and certain antidepressants or anticonvulsants used off-label [5]. Behavioral therapies, such as Cognitive Behavioral Therapy for Insomnia (CBT-I), are also a recommended first-line treatment [6].
What are the common side effects of Belsomra?
Common side effects reported with Belsomra include sleepiness, dizziness, unusual dreams, and diarrhea [1]. Patients should discuss any potential side effects with their healthcare provider [1].
Is Belsomra addictive?
Belsomra is not classified as a controlled substance in the same way as benzodiazepines, which are known for their potential for dependence and abuse [2]. However, like any medication that affects the central nervous system, it should be used as prescribed by a healthcare professional [1].
Who manufactures Belsomra?
Belsomra is developed and manufactured by Merck & Co. [1].
What clinical trials have been conducted for Belsomra?
Merck has conducted numerous clinical trials to evaluate the efficacy and safety of Belsomra across different patient populations and dosages [7]. These trials have assessed its impact on sleep onset latency, wake after sleep onset, and total sleep time, as well as its safety profile [7].
Can generic versions of Belsomra be made?
The availability of generic versions of Belsomra depends on the expiration of its patents and any market exclusivity granted by regulatory bodies [4]. DrugPatentWatch.com can provide detailed information on the patent status and potential for generic competition [4].
What is the cost of Belsomra?
The cost of Belsomra can vary depending on insurance coverage, pharmacy, and dosage [8]. Patients can explore options for cost savings through manufacturer coupons or patient assistance programs [8].
What is the difference between Belsomra and other sleep aids?
Belsomra's unique mechanism of action as an orexin receptor antagonist differentiates it from older sleep medications that act as GABA receptor modulators [2]. This difference may translate to a different side effect profile and a potentially lower risk of dependence for some individuals [2].
Sources:
[1] https://www.belsomra.com/
[2] https://www.drugpatentwatch.com/drugs/belsomra
[3] https://www.drugpatentwatch.com/patents/belsomra
[4] https://www.drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/books/NBK519500/
[6] https://www.hopkinsmedicine.org/health/wellness-and-prevention/is-cognitive-behavioral-therapy-for-insomnia-right-for-you
[7] https://clinicaltrials.gov/ct2/results?cond=&term=belsomra
[8] https://www.goodrx.com/belsomra